Velumani was interviewed toady on CNBC. As always brutally honest. Explained that the valuation that he exited on was fortunate and way above anything that will be seen by Thyro or any Diagnostic till 2028 … till then we have to wait i guess.
but i think thyro will do better and reach old valuation if API can sell their stakes and the approach current MD has to expand to new geography in Africa with reputed technology will be the way ahead.
Velu also said that the organized diagnostic now was much better certified and quality is better.
i wish he once again buy it back …very frugal and made sure all the money spent was to achieve lowest cost
| Subscribe To Our Free Newsletter |
